# Effect of Age and Gender on the PK and Tolerability of Finafloxacin

> **NCT01904162** · PHASE1 · COMPLETED · sponsor: **MerLion Pharmaceuticals GmbH** · enrollment: 40 (actual)

## Conditions studied

- Pharmacokinetic and Tolerability of Finafloxacin

## Interventions

- **DRUG:** 400 mg finafloxacin (2 x 200 mg tablets)

## Key facts

- **NCT ID:** NCT01904162
- **Lead sponsor:** MerLion Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01904162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01904162, "Effect of Age and Gender on the PK and Tolerability of Finafloxacin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01904162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*